Multi-project collaboration with Fred Hutch Cancer Center spans biomarker discovery in bladder cancer and a single cell approach to residual disease detection in acute myeloid leukemia PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a multi-project research collaboration with Fred Hutchinson […]
NMPA approvals for Quanterix SIMOA® instruments and key neurology biomarker assays advance access to ultra-sensitive blood-based testing in China BILLERICA, Mass. & BEIJING — Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biological Technology Co., Ltd. (SSE: 688253.SH), a leading in vitro diagnostics company in China, today announced regulatory approvals […]
Bringing together scientific and technical expertise to advance development of hardware and software aimed at enabling a new wave of AI-driven, autonomous biologics discovery Salt Lake City, Utah: Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, today announced a research collaboration with AstraZeneca to develop […]
Exclusive partnership results in a user-centric, hydrocarbon-cooled centrifuge purpose-built for clinical trials – years ahead of upcoming F-gas regulatory changes in Europe and the U.S. LEESBURG, Va. and QINGDAO, China — Resonant Clinical Solutions – a global clinical solutions partner serving life sciences organizations across the clinical supply chain and sample lifecycle – and Haier Biomedical […]
PacBio Kinnex sequencing will generate full-length transcript data to help advance TychoBio’s drug discovery models MENLO PARK, Calif. and PARIS — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and TychoBio, an AI drug discovery company, today announced a collaboration to generate full-length RNA data that TychoBio will use to train models […]
Initial results presented at HUPO 2026 World Congress demonstrate how the company’s complementary mass spectrometry and Olink biomarker panels can expand biological associations at population scale to advance disease and therapeutic development research Key Takeaways: Thermo Fisher’s complementary proteomic technologies uncovered more than 2,500 new biological associations: Initial findings from the PRECISE-SG100K study identify 2,762 […]
CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development
Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise MONTREAL — CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a strategic partnership with Waters Corporation, a global leader in life sciences and diagnostics, creating a framework to jointly pursue companion diagnostic (CDx) and next-generation […]
Collaboration brings EpiSign’s comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform LONDON, ON and HERZLIYA, Israel — EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for rare-disease interpretation. The collaboration combines EpiSign’s expertise in DNA methylation episignature analysis […]
Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), a pioneer in disease risk detection and preventive health, has signed a USD 6.5 million proteomics service agreement with the Michael J. Fox Foundation. Under the agreement, Nightingale will perform proteomics analyses on 60,000 UK Biobank samples using Alamar Biosciences’ NULISAseq™ Neuro 220 Panel and, at the […]
Key takeaways NIAID and FDA have selected ATCC to advance new approach methodologies (NAMs), including microphysiological systems (MPS) and organoid-based platforms, for infectious disease and oncology research. These latest awards further underscore ATCC’s expertise and leadership role in NAMs, spanning authenticated cells, organoids, MPS, and traceable genomic and biological data. Building on decades of virology […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
